Soba Hospital
Khartoum, Khartoum State, 249, Sudan
Completed
NCT Number: NCT01347593
Prophylactic Ceftizoxime (Cefizox) for Elective Cesarean Delivery
Ceftizoxime (Cefizox) will reduce post Cesarean delivery febrile morbidity.
Completed
Looking for future studies?
Notify MeKey information
Conditions
Age range
14 year–45 year
Sex eligibility
Female
Study type
Interventional
Phase
Phase 4
Primary location
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Elective Cesarean section
Exclusion criteria
- Diabetes severe anaemia allergy
Treatment and study plan
ceftizoxime
Drugceftizoxime (cefizox) injection either after clamping the cord
Other names: cefizox
Primary outcomes
-
reducing post Cesarean section febrile morbidity
Time frame: 4 days
reducing infection rate
Sponsors and collaborators
Lead sponsor
University of Khartoum
Other
Collaborators
- Ministry of Health, Sudan
Registry information
Official study title
Prophylactic Ceftizoxime (Cefizox) for Elective Cesarean Delivery in Soba Hospital Sudan
Important dates
- Study start
- 2011
- Primary completion
- 2011
- Study completion
- 2011
- First posted
- May 4, 2011
- Registry last updated
- Jan 17, 2013
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.